The Arab Drug Company reported earnings results for the first quarter ended September 30, 2021. For the first quarter, the company reported revenue was EGP 144.07 million compared to EGP 148.76 million a year ago. Net income was EGP 25.69 million compared to EGP 31.72 million a year ago. Basic earnings per share from continuing operations was EGP 3.82 compared to EGP 4.7 a year ago.